Milestone Scientific
$ 0.26
-0.04%
24 Feb - close price
- Market Cap 20,270,500 USD
- Current Price $ 0.26
- High / Low $ 0.26 / 0.25
- Stock P/E N/A
- Book Value 0.03
- EPS -0.09
- Next Earning Report 2026-03-27
- Dividend Per Share N/A
- Dividend Yield 0 %
- Next Dividend Date -
- ROA -0.42 %
- ROE -1.36 %
- 52 Week High 1.12
- 52 Week Low 0.22
About
Milestone Scientific, Inc. develops computer-controlled anesthetic delivery devices for the medical and dental markets in the United States, China, and internationally. The company is headquartered in Livingston, New Jersey.
Analyst Target Price
$1.00
Quarterly Earnings
| Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported Date | 2025-11-13 | 2025-08-14 | 2025-05-14 | 2025-03-27 | 2024-11-13 | 2024-08-14 | 2024-05-15 | 2024-03-29 | 2023-11-14 | 2023-08-14 | 2023-05-10 | 2023-03-30 |
| Reported EPS | -0.01 | -0.02 | -0.0261 | -0.03 | -0.02 | -0.02 | -0.02 | -0.03 | -0.02 | -0.03 | -0.02 | -0.03 |
| Estimated EPS | -0.02 | -0.01 | -0.01 | -0.01 | -0.01 | -0.01 | -0.02 | -0.02 | -0.02 | -0.02 | -0.03 | -0.03 |
| Surprise | 0.01 | -0.01 | -0.0161 | -0.02 | -0.01 | -0.01 | 0 | -0.01 | 0 | -0.01 | 0.01 | 0 |
| Surprise Percentage | 50% | -100% | -161% | -200% | -100% | -100% | 0% | -50% | 0% | -50% | 33.3333% | 0% |
Next Quarterly Earnings
| Dec 2025 | |
|---|---|
| Reported Date | 2026-03-27 |
| Fiscal Date Ending | 2025-12-31 |
| Estimated EPS | -0.01 |
| Currency | USD |
Next Dividend Records
| Dividend per share (year): | - |
| Dividend Yield | - |
| Next Dividend Date | - |
| Ex-Dividend Date | - |
Recent News: MLSS
2026-02-24 14:52:31
Milestone Scientific Inc. has launched its CompuFlo Advisor Program to accelerate the adoption of its precision epidural technology. This initiative, starting February 1, 2026, targets high-volume pain and anesthesia practices in specific U.S. Medicare jurisdictions to strengthen reimbursement pathways and generate clinical evidence. The program aims to support physicians, simplify billing, and build a scalable commercial infrastructure for long-term growth and broader market penetration.
2026-02-24 02:52:31
Milestone Scientific Inc. has launched its CompuFlo® Advisor Program to accelerate commercial adoption and increase recurring disposable revenue for its computerized drug delivery instruments. The program targets high-volume interventional pain and anesthesia practices in key Medicare Administrative Contractor (MAC) jurisdictions to generate clinical data and optimize long-term Medicare reimbursement rates. The ultimate goal is to transition CPT® code 0777T from Category III to Category I status, enhancing broader commercial adoption and revenue visibility.
2026-02-23 13:29:22
Milestone Scientific Inc. (MLSS) has launched its CompuFlo® Advisor Program, beginning February 1, 2026, to enhance Medicare reimbursement for CPT 0777T, which is used for interventional pain and anesthesia procedures. The program targets key Medicare Administrative Contractor (MAC) jurisdictions and aims to generate 1,000–2,000 case submissions in six months to support the transition of CPT 0777T from Category III to Category I status. This initiative seeks to drive commercial adoption and increase recurring revenue, with plans for national expansion.
2026-02-01 19:28:16
The provided article snippet is incomplete, containing only the stock symbol "MSN". Therefore, it is impossible to generate a meaningful summary or extract detailed content.
2026-01-24 05:59:03
Milestone Scientific (NYSE American:MLSS) announced a lock-up agreement with BP4 S.r.l., a significant shareholder owning 11.31% of its stock. Under this agreement, BP4 will not sell or transfer its shares for twelve months after a $2.5 million offering, with exceptions allowing partial distribution if Milestone Scientific's stock reaches specified price targets ($0.50, $0.70, and $0.90) for ten consecutive trading days. The agreement aims to stabilize the stock following the offering and was approved by BP4's shareholders.
2026-01-21 20:27:57
Milestone Scientific has entered into an amended lock-up agreement with Innovest S.p.A., which controls BP4 S.r.l., a holder of 11.31% of Milestone Scientific's stock. Under the agreement, BP4 will not sell its shares for twelve months following a $2.5 million offering, with exceptions allowing phased distribution based on stock performance reaching price thresholds of $0.50, $0.70, and $0.90. This news follows Milestone Scientific's positive Q3 2025 earnings and other corporate developments.
